Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.
Ci X, Chen S, Zhu R, Zarif M, Jain R, Guo W, Ramotar M, Gong L, Xu W, Singh O, Mansouri S, Zadeh G, Wei GH, Xu W, Bristow R, Berlin A, Koritzinsky M, van der Kwast T, He HH.
Ci X, et al. Among authors: chen s.
BMC Cancer. 2024 Jun 18;24(1):744. doi: 10.1186/s12885-024-12505-1.
BMC Cancer. 2024.
PMID: 38890593